Big Developments for this Giant Pharma could Soon Mean a Healthier Share Price
By Malcolm Stacey | Wednesday 20 April 2022
Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Hello Share Tempters. There are two very big British pharmas you could invest in. A long time ago I chose GlaxoSmithKline (GSK), rather than AstraZeneca (AZN). I sometimes regret that choice as AstraZeneca seems to have been the more dynamic company, including with a Covid vaccine for example. But I would not swap holdings now, as I think things are happening at GSK that could improve its share price.
You must be a registered member to read this story
ShareProphets is reader-supported journalism
Join us for free and gain access to three articles per month
Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.